Cingulate CING
NASDAQ CING
$5.20 -0.03 (-0.67%)
As of: Sep 22, 2026 · 10:26 AM EDT

Cingulate (CING) Profit After Tax (2021 - 2026)

Cingulate's (CING) quarterly Profit After Tax came in at -$5.9 million in Q2 2026, down 17.8% on a YoY basis from -$7.1 million in Q2 2025, and up 6.42% quarter-over-quarter from -$6.3 million in Q4 2025.

Analysis

Cingulate (CING) Profit After Tax (2021 - 2026) Analysis & Trends

Cingulate (CING) has reported Profit After Tax for 6 consecutive years, with -$5.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Profit After Tax fell 17.8% year-over-year to -$5.9 million; the trailing twelve-month figure through Jun 2026 stood at -$24.5 million (down 27.48% YoY), and the FY2025 full-year result was -$22.4 million, down 35.57% from the prior year.
  • Profit After Tax rose to -$5.9 million in Q2 2026 per CING's latest filing, from -$6.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$3.0 million in Q1 2024 and bottomed at -$7.3 million in Q3 2025.
  • Historically, Profit After Tax has averaged -$5.1 million across 5 years, with a median of -$5.0 million in 2025.
  • The widest YoY moves for Profit After Tax: up 73.66% in 2022, down 275.1% in 2022.
  • Over 5 years, Profit After Tax stood at -$4.6 million in 2022, then slumped by 50.6% to -$6.9 million in 2023, then gained by 10.15% to -$6.2 million in 2024, then dropped by 0.67% to -$6.3 million in 2025, then increased by 6.42% to -$5.9 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$5.9 million, -$6.3 million, and -$7.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 5.53 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.62 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 3.26 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -248.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.40 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 438.21 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -644.37 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 237.01 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -5.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.87 Mn
Dec 31, 2025 -6.27 Mn
Sep 30, 2025 -7.34 Mn
Jun 30, 2025 -4.98 Mn
Mar 31, 2025 -3.85 Mn
Dec 31, 2024 -6.23 Mn
Sep 30, 2024 -4.13 Mn
Jun 30, 2024 -3.23 Mn
Mar 31, 2024 -2.97 Mn
Dec 31, 2023 -6.93 Mn
Sep 30, 2023 -5.98 Mn
Jun 30, 2023 -6.62 Mn
Mar 31, 2023 -4.00 Mn
Dec 31, 2022 -4.60 Mn
Sep 30, 2022 -4.03 Mn
Jun 30, 2022 -4.04 Mn
Mar 31, 2022 -5.00 Mn
Dec 31, 2021 -2.65 Mn
Sep 30, 2021 -15.29 Mn
Jun 30, 2021 -1.43 Mn
API Access

Cingulate Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CING&period=max&api_key=YOUR_API_KEY